In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

mRNA Process Development and Manufacturing Summit

Sep 20, 2022 - 09:00 AM - Sep 22, 05:00 PM
Hanson Wade
Hilton Boston Back Bay
40, Dalton St

ZIP: 02115
Phone: +1 617 455 4188

Ticket Price: USD 2499.00 - USD 4897.00

Accelerating mRNA Drug Substance Process Scale Up and Manufacturing

Built with biopharmaceutical industry insights, this in-person conference will bring together key opinion leaders to delve deep into the key remaining challenges associated with mRNA process scale up and manufacturing towards regulatory harmonization by optimizing in vitro transcription, purification and analytical validation mRNA drug substance.

With 20+ pioneering speakers from large pharma, innovative biotech and KOLs of academia who are ready to discuss how the future mRNA process development and manufacturing is shaping in accordance with regulatory expectations and emerging tools and technologies to support the development of scalable and commercially viable mRNA-based therapeutics and vaccines, join us in Boston to hear how they address the major challenges facing the industry.

Tickets:  https://go.evvnt.com/1170386-1?pid=1052
Brochure: https://go.evvnt.com/1170386-3?pid=1052

Drug Developer - Conference + 2 Workshops: USD 4097.00,
Drug Developer - Conference + 1 Workshop: USD 3498.00,
Drug Developer - Conference Only: USD 2899.00,
Academic - Conference + 2 Workshops: USD 3497.00,
Academic - Conference + 1 Workshop: USD 2998.00,
Academic - Conference Only: USD 2499.00,
Service Provider - Conference + 2 Workshops: USD 4897.00,
Service Provider - Conference + 1 Workshop: USD 4198.00,
Service Provider - Conference Only: USD 3499.00

Speaker Details

Andreas Kuhn, SVP - RNA Biochemistry and Manufacturing, BioNTech SE, Dipendra Gyawali, Senior Scientist - Analytical Development, Moderna, Dushyant Varshney, CTO, Arcturus Therapeutics, Elaine Peters, Director - Cell and Gene Therapy Analytical Capabilities, Genentech, Emily English, Senior Director - Quality, Cartesian Therapeutics, Harris Makatsoris, Professor - Sustainable Manufacturing Systems, King's College London, Jin Zhou, Executive Director - Process Development; mRNA and Protein Biologics, Ultragenyx Pharmaceutical, Madelyn Johnstone- Robertson, BioProcess Engineer, Afrigen Biologics, Martin Carvalho, Head - Quality, mRNA Centre of Excellence, Sanofi, Nili Schutz, COO, Art Bioscience, Petro Terblanche, Managing Director, Afrigen Biologics, Philippe Alexandre, Gilbert Senior Program Officer - CMC, Bill and Melinda Gates Foundation, Rachit Jain, Director - Process Development, Tessera Therapeutics, Serena Smith, Director - Strategy and Market Intelligence, ThermoFisher Scientific, Srinivasulu Bandi, Director - BioProcess Development, Senda Biosciences, Shefal Parikh, Director - mRNA Process Development, Beam Therapeutics, Steve Pascolo, Professor, University Hospital of Zürich, Xinyue Zhang, Investigator - mRNA Process and Analytical Development, GeneLeap Biotech, Kristie Bloom, Researcher, University of the Witwatersrand, Thomas Aune, Professor, Vanderbilt University Medical Center, Zheng Meng, Senior Director - Analytical Development, Ultragenyx Pharmaceutical, Anna Senczuk, Director - Process Development and mRNA CMC, Seqirus, Ruchi Shah, Associate Director, Eli Lilly and Company

Event Categories
Keywords: Conference , pharmaceutical


Events Calendar

28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 1

Event Location


VIP Life Time Subscription to our Newsletters!